Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients
Author(s) -
Luís F. LópezCortés,
María TrujilloRodríguez,
Alicia Báez-Palomo,
Omar J. BenMarzoukHidalgo,
Beatriz Domínguez-Molina,
Yusnelkis MilanésGuisado,
Núria Espinosa,
Pompeyo Viciana,
Alicia GutiérrezValencia
Publication year - 2018
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiy136
Subject(s) - hepatitis c virus , immunology , immune system , cd8 , cd38 , virology , viral load , cd14 , biology , hepatitis c , t cell , medicine , virus , stem cell , cd34 , genetics
There are contradictory data about the influence that hepatitis C virus (HCV) has on immune activation and inflammation in patients coinfected with human immunodeficiency virus (HIV) and HCV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom